Arca
Skip to content
Tools
Tools

Bilirubin Assay On The Omni S Analyzer

Bilirubin (Total And Unbound) In The Neonate Test System. 510(k) K040174, from Roche Diagnostics Corp. (Indianapolis, IN). Product code MQM, class 1.

As of Nov 18, 2026, K040174 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on May 14, 2004 after 109 days, with no recalls tied to it in FDA's recall database.

  • Review time: 109 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Roche Diagnostics OMNI S Analyzer is a fully automated critical care analyzer intended to be used for the measurement of pH, PO2, PCO2, sodium, potassium, ionized calcium, chloride, hematocrit, glucose, lactate, urea/BUN, bilirubin, total hemoglobin, oxygen saturation, oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin in samples of whole blood, serum, plasma and aqueous…

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Traditional
Received
Jan 26, 2004
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1113

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.